Immuneering (IMRX) Return on Assets (2021 - 2026)
Immuneering (IMRX) recorded quarterly Return on Assets of 0.0% in Q1 2026, down 3.86% quarter-over-quarter from 0.0% in Q4 2025, and up 1.0% on a YoY basis from 0.0% in Q1 2025.
Immuneering (IMRX) Return on Assets (2021 - 2026) Analysis & Trends
Immuneering's Return on Assets history runs 6 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Assets rose 1.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (up 1.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets was 0.0% for Q1 2026 at Immuneering, down from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.01% in Q2 2025.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.0% in 2023.
- The sharpest annual moves came in 2024 and 2025: Return on Assets slipped 1 bps in 2024, then gained 1 bps in 2025.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then slipped by 28 bps to 0.01% in 2023, then plunged by 100 bps to 0.01% in 2024, then surged by 77 bps to 0.0% in 2025, then fell by 4 bps to 0.0% in 2026.
- The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -0.01% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.01% |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |